Last week we had the privilege to sit down with a physician who shared challenges in planning a clinical trial. She had been working for years on this trial, and continued to face resource consuming and frustrating issues. Recently she attended a two hour meeting where some basic questions were left unanswered, and – even more frustrating – the traditional paths to getting those answers were not promising.
One, she was struggling to find subjects to qualify for the trial. Two, she was wondering about what investigator sites might be appropriate.
She knew that there were others who were conducting trials on this disease, but couldn’t quickly and easily get at key information about those trials. If she could find the right trials and learn about the investigator sites used, it could help her with strategies to find potential sites and qualified subjects.
Enter Clinical Collections. More…
In his book Open Innovation: The New Imperative for Creating and Profiting from Technology, Henry Chesbrough describes the centralized R&D departments of modern industry as “a series of fortified castles” behind whose walls the business of innovation is conducted in closely guarded secrecy. Forays outside the castle keep were rare. Visitors inside were equally so.
Numerous articles, blog posts, and interviews have made it clear that this approach to innovation in the biosciences — and in the pharmaceutical industry, specifically — is broken. In many cases, R&D budgets have been cut and research pipelines now focus on the most lucrative (or least risky) areas of development. The high cost of failed trials, regulatory pressures and even, perhaps, internal cultural habits have conspired to cause many companies to become risk-adverse. Hundreds of new ideas die on the R&D vine as a result. More…
The Lilly Clinical Open Innovation team is made up of scientists and technologists who apply open innovation principles to the world of clinical research. We’re folks with computers in one hand and lab coats in the other.
Our mission includes making publicly-available clinical data more consumable for a mass audience, in ways that are easy to view and put to good use. To demonstrate, we’re excited to make available our first tool - Clinical Collections.
The Clinical Collections tool takes data published by the NIH on ClinicalTrials.gov and makes it more consumable. The data on ClinicalTrials.gov is very useful, but not so easy to sift through and work with. Clinical Collections ”webifies” clinical trials data so you can search, filter and visualize the data in a number of different views.
In addition, you can save your collections and views. Just bookmark the URL and you can reuse and share your collections with others. Soon there will be more options to add trials to your collection, and we’ll introduce a way to follow them. Imagine a kind of Pinterest for clinical trial data.
For now, check out the video and give Clinical Collections a try at ClinicalCollections.org. It’s free and available for anyone to use.
How might you use Clinical Collections in your work? Are there any features you’d like us add? Please leave a comment below.